meRfi®-GM
Carcinogenesis / Oncogenesis / Tumorigenesis & Cyclomodulins
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Cyclomodulins can disrupt key processes in eukaryotic cells, potentially leading to pathological changes and contributing to oncogenesis
Cyclomodulins can dysregulate the cell cycle, impact cell differentiation and apoptosis, and play a role in colonic oncogenesis
Some Escherichia coli strains produce toxins designated cyclomodulins (CMs) which interfere with the [eukary…
References (Sources)
- High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer
- Microbial and viral pathogens in colorectal cancer
- Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli
- The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development
- The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis